Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older, of any gender
- People whose breast cancer has been confirmed by laboratory testing to be a specific type called invasive lobular carcinoma
- People whose pathology report shows or has been reviewed to confirm a particular cellular feature called apocrine differentiation
- People whose breast cancer tests negative for hormone receptors
- People who were diagnosed and/or treated at one of the hospitals or centres taking part in this trial
- People for whom the key medical and pathology records are available
- People for whom follow-up health information is available, where relevant
Who may not be able to join:
- People whose cancer is a purely ductal type, with no lobular invasive component present
- People whose breast tumour originated from a cancer elsewhere in the body (not a primary breast cancer)
- People whose pathology records are incomplete or insufficient to confirm the required diagnosis
- People whose essential clinical information is missing from their records
- People who have not given consent for their past medical data to be used in research, in cases where local rules require this
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Francesco Milardi, MD, Veneto Institute of Oncology IRCCS
Phone: 049 821 5500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinicopathological characterization of apocrine invasive lobular breast carcinoma
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.